SHED-derived exosomes ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells.

Kuan Yang, Baize Zhang, Yingyue Zhang, Xiaojing Wang, Xiao Yuan

Department of Orthodontics, The Affiliated Hospital of Qingdao University, Qingdao, China.Department of Orthodontics, The Affiliated Hospital of Qingdao University, Qingdao, China. · pubmed

Paper

Abstract

This study aims to explore the therapeutic efficacy of stem cells from human exfoliated deciduous teeth-derived exosomes (SHED-Exo) in age-related osteoporosis (OP) and clarify its mechanism via mitophagy activation in senescent bone marrow mesenchymal stem cells (BMSCs).

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper claims that SHED-derived exosomes can ameliorate age-related osteoporosis by activating mitophagy in senescent bone marrow mesenchymal stem cells. This research is relevant as it addresses a specific age-related disease and explores a potential therapeutic approach that targets underlying cellular mechanisms associated with aging.

Author of this paper? Send a correction.